Evidence map›Paper›PMID 39193320›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2024

Telemedicine at a University Ophthalmology Practice During the Beginning of the COVID-19 Pandemic.

Anthony C Oganov, Timothy Y Chou, Paris M Hanson, Azin Abazari, Preston Kung, Sarah B Weissbart, Jacqueline N Lenoci, Robert A Honkanen

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anthony C OganovDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.
Timothy Y ChouDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.ORCID 0000-0003-4351-5533
Paris M HansonDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.
Azin AbazariDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.
Preston KungDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.
Sarah B WeissbartDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.
Jacqueline N LenociDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.
Robert A HonkanenDepartment of Ophthalmology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11974, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The aim of the research was to evaluate the use of teleophthalmology at a university practice during the COVID-19 pandemic, specifically examining precision, effectiveness, and patient satisfaction. Patients and Methods: Telemedicine visits were offered to new and established patients requesting appointments with the Stony Brook University Department of Ophthalmology between March 30 and June 2, 2020. Records from these visits were reviewed for chief complaint, past medical and ocular history, diagnoses, treatment/management, and providers' sub-specialty. Precision was determined by comparing agreement between diagnoses of the telemedicine visit with those of the subsequent in-person visit. The decision to follow up in person was made by the physician and patient. Diagnostic precision as well as progression, improvement, or stability of patients' symptoms were determined by the physician's assessment at follow-up visits. Post-telemedicine visit satisfaction surveys were sent to all patients. Results: Telemedicine visits were offered to 783 patients, 520 (66.4%) of whom accepted. Of these 520 patients, 409 (78.7%) were established and 105 (20.2%) had in-person, follow-up visits. Overall, the diagnostic precision of the follow-up visits was 89.5%. Precision differed significantly across ophthalmologic subspecialties. Of the patients who had in-person follow-up visits, 56.8% remained stable, 32.4% improved, and 10.8% worsened. Established patients presented with more extensive ocular histories/procedures and experienced a higher percentage of worsening symptoms/disease stage compared to new patients. Oculoplastics/orbit was the most prevalent diagnostic subspecialty that worsened. Surveys were sent to all patients completing telemedicine visits, 15.0% of whom responded. Overall satisfaction was 91.9%, although only 23.0% of respondents preferred telemedicine to an in-office visit. Conclusion: Telehealth provides high levels of precision and patient satisfaction for a wide range of ophthalmologic visits, although most patients still prefer in-office examinations. Employing teleophthalmology for follow-up and emergency care may provide patients with an effective alternative during pandemic situations and beyond.

Indexed as

coronavirusteleglaucomatelehealthTeleophthalmologyteleretina

Identifiers

PMID39193320
PMCPMC11348924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.